This increase in the feeling of satiety, provided by leptin, leads to leptin blocking ghrelin and reducing the indirect feeling of pleasure during food intake
There arent any official standards or guidelines on microdosing, as its not backed by the FDA, so there is no magic number that may work for one person versus another
Kristofi R, Bodegard J, Norhammar A et al (2021) Cardiovascular and renal disease burden in type 1 compared with type 2 diabetes: a two-country nationwide observational study
In addition, exendin-4 treatment reduced lipid accumulation in human primary monocytes and THP-1-derived macrophages stimulated by ox-LDL [15]
This triggers several mechanisms: enhanced insulin secretion in response to food, suppression of glucagon (which raises blood sugar), delayed gastric emptying, and reduced appetite signals
To better understand how the field is evolving and where it might go next DDN spoke with Jan Jezek, Chief Scientific Officer at Arecor Therapeutics, about the scientific challenges, delivery innovations, and future opportunities surrounding GLP-1 therapies